UMIN ID: UMIN000022179
Registered date:02/05/2016
The prospective study of denosumab for the treatment of osteoporosis in hemodialysis patients
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Osteoporosis |
| Date of first enrollment | 2016/05/02 |
| Target sample size | 35 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Patients will be injected subcutaneously with 60 mg of denosumab every 6 months for 60 months |
Outcome(s)
| Primary Outcome | Change in bone mineral density(BMD) at distal radius,P1NP and TRACP-5b |
|---|---|
| Secondary Outcome | Change in Ca,iP,intact-PTH and side effect |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Patient who have the contraindication for denosumab |
Related Information
| Primary Sponsor | Yujinkai Medical Corporation Yujin-yamazaki Hospital |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Yujinkai Medical Corporation Yujin-yamazaki Hospital |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Daisuke Nagasaku |
| Address | 80 Takegahana-cho,Hikone-shi,Shiga-ken Japan 522-0044 |
| Telephone | 0749-23-1800 |
| dnagasaku@yujin-yamazaki.co.jp | |
| Affiliation | Yujinkai Medical Corporation Yujin-yamazaki Hospital Department of Intenal Medicine |
| scientific contact | |
| Name | Daisuke Nagasaku |
| Address | 80 Takegahana-cho,Hikone-shi,Shiga-ken Japan |
| Telephone | 0749-23-1800 |
| dnagasaku@yujin-yamazakii.co.jp | |
| Affiliation | Yujinkai Medical Corporation Yujin-yamazaki Hospital Department of Intenal Medicine |